Linshi Zhang

812 total citations
15 papers, 437 citations indexed

About

Linshi Zhang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Linshi Zhang has authored 15 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Linshi Zhang's work include Cancer-related molecular mechanisms research (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and RNA modifications and cancer (3 papers). Linshi Zhang is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and RNA modifications and cancer (3 papers). Linshi Zhang collaborates with scholars based in China, Madagascar and New Zealand. Linshi Zhang's co-authors include Weilin Wang, Yingcai Yan, Xiaohu Zhou, Jiarong Zhou, Haiyang Xie, Dongkai Zhou, Shusen Zheng, Yang Kong, Wenhao Ge and Lufei Zhang and has published in prestigious journals such as Cancer Letters, BioMed Research International and Oncotarget.

In The Last Decade

Linshi Zhang

15 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linshi Zhang China	12	320	236	49	46	44	15	437
Yingcai Yan China	12	265 0.8×	189 0.8×	41 0.8×	50 1.1×	43 1.0×	16	389
Jingwu Li China	9	244 0.8×	222 0.9×	59 1.2×	28 0.6×	24 0.5×	33	390
Junguo Bu China	13	229 0.7×	165 0.7×	92 1.9×	68 1.5×	47 1.1×	23	393
Xiangjie Sun China	12	470 1.5×	453 1.9×	115 2.3×	137 3.0×	52 1.2×	27	748
Bao‐Ye Sun China	12	169 0.5×	136 0.6×	104 2.1×	47 1.0×	23 0.5×	22	370
Manling Huang China	10	309 1.0×	204 0.9×	138 2.8×	93 2.0×	24 0.5×	19	584
Zhongmin Jiang China	15	371 1.2×	217 0.9×	104 2.1×	78 1.7×	13 0.3×	40	611
Tiening Zhang China	6	168 0.5×	126 0.5×	98 2.0×	70 1.5×	40 0.9×	10	335
Zehua Wang China	13	275 0.9×	187 0.8×	185 3.8×	103 2.2×	23 0.5×	32	562

Countries citing papers authored by Linshi Zhang

Since Specialization

Citations

This map shows the geographic impact of Linshi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linshi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linshi Zhang more than expected).

Fields of papers citing papers by Linshi Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linshi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linshi Zhang. The network helps show where Linshi Zhang may publish in the future.

Co-authorship network of co-authors of Linshi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Linshi Zhang. A scholar is included among the top collaborators of Linshi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linshi Zhang. Linshi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhang, Linshi, Zhe Zhang, Xiwang Zheng, et al.. (2023). A novel microRNA panel exhibited significant potential in evaluating the progression of laryngeal squamous cell carcinoma. Non-coding RNA Research. 8(4). 550–561. 3 indexed citations

Zhou, Jiarong, Wenzhe Wang, Biwen Lei, et al.. (2021). Automatic Detection and Classification of Focal Liver Lesions Based on Deep Convolutional Neural Networks: A Preliminary Study. Frontiers in Oncology. 10. 581210–581210. 57 indexed citations

Dai, Fengsheng, Yongyan Wu, Yan Lü, et al.. (2020). Crosstalk between RNA m6A Modification and Non-coding RNA Contributes to Cancer Growth and Progression. Molecular Therapy — Nucleic Acids. 22. 62–71. 64 indexed citations

Yan, Yingcai, Hao Xu, Linshi Zhang, et al.. (2019). <p>RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma</p>. OncoTargets and Therapy. Volume 12. 1691–1703. 27 indexed citations

Wang, Wei, Zhenhua Hu, Huilin Zheng, et al.. (2019). Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo. BioMed Research International. 2019. 1–12. 7 indexed citations

Zhang, Linshi, Jiarong Zhou, Yingcai Yan, et al.. (2019). Excipient-free nanodispersion of 7-ethyl-10-hydroxycamptothecin exerts potent therapeutic effects against pancreatic cancer cell lines and patient-derived xenografts. Cancer Letters. 465. 36–44. 7 indexed citations

Zhou, Jiarong, Linshi Zhang, Huilin Zheng, et al.. (2019). Identification of chemoresistance‐related mRNAs based on gemcitabine‐resistant pancreatic cancer cell lines. Cancer Medicine. 9(3). 1115–1130. 26 indexed citations

Xu, Hao, Linshi Zhang, Xiaohui Qian, et al.. (2019). GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells. Experimental and Therapeutic Medicine. 18(4). 2608–2616. 19 indexed citations

Kong, Yang, Lufei Zhang, Tianyu He, et al.. (2018). High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma. BioMed Research International. 2018. 1–9. 26 indexed citations

10.

Kong, Yang, Lufei Zhang, Yu Huang, et al.. (2017). Pseudogene PDIA3P1 promotes cell proliferation, migration and invasion, and suppresses apoptosis in hepatocellular carcinoma by regulating the p53 pathway. Cancer Letters. 407. 76–83. 54 indexed citations

11.

He, Tianyu, Lufei Zhang, Yang Kong, et al.. (2017). Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis. International Journal of Oncology. 51(6). 1722–1730. 46 indexed citations

12.

Yan, Yingcai, Linshi Zhang, Xiaohu Zhou, et al.. (2016). Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma. OncoTargets and Therapy. Volume 9. 3925–3937. 13 indexed citations

13.

Zhang, Lufei, Tianyu He, Yingcai Yan, et al.. (2016). Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma. BioMed Research International. 2016. 1–5. 13 indexed citations

14.

Zhou, Xiaohu, Linshi Zhang, Yingcai Yan, et al.. (2016). MicroRNA‐761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin‐2. Cancer Science. 107(4). 424–432. 63 indexed citations

15.

Wang, Weilin, Pengfei Huang, Rong Kong, et al.. (2015). BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis. Oncotarget. 6(24). 20252–20265. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact